Latest Breaking News On - Castle biosciences inc - Page 4 : comparemela.com

Castle Biosciences Reports First Quarter 2024 Results

Castle Biosciences Reports First Quarter 2024 Results
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

United statesCastle biosciencesProgram registriesNational cancer institute surveillanceSee the companyCastle biosciences incSecurities exchangeNational comprehensive cancer networkAmerican joint committee on cancer staging manualMental healthMedicare contractorsDecisiondx melanoma classQuarter ended marchPath melanomaCypher barrettAdjusted gross margin

Castle Biosciences Kicks off Skin Cancer Awareness Month with a Ribbon Cutting to Celebrate the City of Friendswood s Designation as a Sun Safe Leadership Model City by IMPACT Melanoma

Castle Biosciences Kicks off Skin Cancer Awareness Month with a Ribbon Cutting to Celebrate the City of Friendswood s Designation as a Sun Safe Leadership Model City by IMPACT Melanoma
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesLas vegasCity of friendswoodNew yorkCastle biosciencesDavid cotterDeb girardJulie bainAnne ramseyCastle decisiondxOlga villaverdeMontel williamsDerek maetzoldMelanoma research foundationCancer foundationSkin cancer foundation

Insider Selling: Castle Biosciences, Inc (NASDAQ:CSTL) Insider Sells 1,947 Shares of Stock

Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) insider Derek J. Maetzold sold 1,947 shares of the business’s stock in a transaction that occurred on Friday, April 12th. The shares were sold at an average price of $20.35, for a total value of $39,621.45. Following the completion of the transaction, the insider now directly owns […]

Derekj maetzoldCastle biosciencesTower research capitalSecurities exchange commissionBluepath capital managementCastle biosciences incOsaic holdings incCastle biosciences company profileRoyal bankDell groupGet free reportExchange commissionPath capital managementResearch capitalOsaic holdingsMypath melanoma

Castle Biosciences, Inc (NASDAQ:CSTL) Insider Derek J Maetzold Sells 1,947 Shares of Stock

Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) insider Derek J. Maetzold sold 1,947 shares of the firm’s stock in a transaction that occurred on Friday, April 12th. The shares were sold at an average price of $20.35, for a total value of $39,621.45. Following the completion of the sale, the insider now directly owns […]

United kingdomCastle biosciencesDerekj maetzoldRice hall james associatesYork mellon corpSecurities exchange commissionCastle biosciences incCambridge investment research advisors incCastle biosciences company profileJpmorgan chase coUs bancorpGet free reportExchange commissionBiosciences trading downHall jamesNew york mellon corp

Insider Selling: Castle Biosciences, Inc (NASDAQ:CSTL) Director Sells 9,152 Shares of Stock

Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) Director Daniel Bradbury sold 9,152 shares of the business’s stock in a transaction dated Thursday, April 4th. The shares were sold at an average price of $21.45, for a total value of $196,310.40. Following the completion of the sale, the director now directly owns 22,782 shares of […]

United statesCastle biosciencesDaniel bradburySecurities exchange commissionFirst republic investment management incBaird financial group incCastle biosciences company profileTower research capitalPricet rowe associates incAmerican international group incCastle biosciences incGet free reportDirector daniel bradburyExchange commissionInternational groupRepublic investment management